•   
  •   
  •   

Politics Pfizer CEO: ‘Disappointed’ in presidential debate, vows no political pressure on Covid shot

23:00  01 october  2020
23:00  01 october  2020 Source:   politico.com

Pfizer Urged to Wait for November to Seek Vaccine Authorization

  Pfizer Urged to Wait for November to Seek Vaccine Authorization Pfizer Inc. should wait until at least late November before seeking FDA authorization of its Covid-19 vaccine to meet rigorous safety standards, more than 60 leading researchers and bioethicists said. The letter, obtained by Bloomberg Law and verified by six signatories, was sent Friday following reports that Pfizer’s clinical trial will yield conclusive results in October. That would likely put the company ahead of Moderna Inc. and AstraZeneca PLC and other promising vaccine candidates.But the researchers said Pfizer’s clinical trial needs to monitor participants for at least two months after they received the second dose.

The CEO of Pfizer — one of the frontrunners in the coronavirus vaccine race — said in a staff memo Thursday that the company wouldn’t cave to political pressure to rush its vaccine to market, while at the same time decrying "those who argue for delay."

Albert Bourla wearing a suit and tie: Albert Bourla, chief executive officer of Pfizer, waits at the New York Stock Exchange. © Drew Angerer/Getty Images Albert Bourla, chief executive officer of Pfizer, waits at the New York Stock Exchange.

“Tuesday night I joined the millions of Americans who tuned in to the Presidential debate. Once more, I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts,” Albert Bourla said in an internal memo obtained by POLITICO.

Donald Trump sidesteps call to condemn white supremacists — and the Proud Boys were 'extremely excited' about it

  Donald Trump sidesteps call to condemn white supremacists — and the Proud Boys were 'extremely excited' about it Debate moderator Chris Wallace asked if Donald Trump would urge groups to stand down and avoid contributing to the violence. He sidestepped.Watch the key moments from the first presidential debate

President Donald Trump said Tuesday during the first 2020 presidential debate that the country is “weeks away from a vaccine” contradicting federal health officials who project a shot will be available at the end of the year or early 2021. Democratic candidate Joe Biden countered that on “the whole notion of a vaccine — I don’t trust him at all, you don’t either.”

Bourla has repeatedly said that Pfizer could apply for emergency authorization from the FDA sometime in October, the most ambitious target laid out by any of the vaccine developers whose shots are now in late-stage U.S trials.


Video: Legislation needed to change health care ‘dramatically’: Mulvaney (Fox Business)

His memo to staff Thursday sticks to that goal while also asserting Pfizer's independence in the face of strong pressure from the White House to deliver a shot before Election Day.

A woman could never behave that way and be president

  A woman could never behave that way and be president Words that Hillary Clinton could never utter in 2016, Joe Biden's campaign will now use on T-shirts. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.getMedianetNativeAds(true); }); "Whether you're a woman, a person of color or someone from an identity that's in any other way marginalized, it's difficult to see yourself in the position of these leaders, because they're operating in a world that you're not permitted to operate in," said Laura Palumbo of the National Sexual Violence Resource Center.

"Now, we are approaching our goal and despite not having any political considerations with our pre-announced date, we find ourselves in the crucible of the U.S. Presidential election," Bourla wrote, later adding "we would never succumb to political pressure."

Trump last week said he might block FDA's proposal to strengthen its standards for allowing emergency use of Covid-19 vaccines — standards that would almost certainly rule out having a vaccine ready for use by early November. The president also accused FDA of acting based on political considerations, rather than science, without offering any evidence to support the claim.

The plan for Pfizer's ongoing Phase III vaccine trial allows the company to take its first look at data when just 32 participants, out of a planned 44,000, have reported Covid-19 infections.

The CEO of another coronavirus vaccine frontrunner, Moderna, said this week that the company would not file for authorization before late November; AstraZeneca’s U.S. trials are still stalled pending FDA investigation of a serious side effect. Other shots are still in early trials or just entered the final, monthslong phase recently.

Pfizer and its partner BioNTech contracted with the U.S. government in July to provider 100 million doses of their shot to Health and Human Services and the Pentagon for $1.95 billion and an option to buy 500 million more doses.

The moment a fly landed on Vice President Pence's head memorialized with a bobblehead .
The bobblehead shows Pence standing at a podium in his debate-night suit, next to a plexiglass-like barrier, with a fly on his head. Get daily updates on the Packers during the season. "Social media has been abuzz with talk of the fly at last night’s debate, and when we received several requests for a bobblehead with Pence and the fly, we knew we had to get to work," Phil Sklar, National Bobblehead Hall of Fame and Museum co-founder and CEO, said in a press release. "We think this will be another fun bobblehead to put a smile on people’s faces as they look back at 2020.

usr: 1
This is interesting!